| 1 | 2699-11-8 | cyclohexylidene hydroperoxide | C6H12O4 | 148.15708 | | |
| 2 | 2699-12-9 | di-(1-hydroperoxycyclohexyl)peroxide | C12H22O6 | 262.3 | 83-83 °C | |
| 3 | 2699-13-0 | 3-Methoxycyclohexene | C7H12O | 112.17 | | |
| 4 | 2699-79-8 | sulfuryl fluoride | F2O2S | 102.06 | -121,4°C | mL SO2F2/100mL solvent: 4–5, H2O; 24–27, alcohol; 210–220, toluene; 136–138, CCl4, [MER06] |
| 5 | 26990-57-8 | 1,3-Oxathiolane, 2-methyl-2-propyl- | C7H14OS | 146.25 | | |
| 6 | 26990-59-0 | 1,3-Oxathiolane, 2-butyl-2-methyl- | C8H16OS | 160.28 | | |
| 7 | 26990-69-2 | 1,3-DIMETHYL-5-MORPHOLINO-1H-PYRAZOLE-4-CARBALDEHYDE | C10H15N3O2 | 209.24 | 73-75°C | |
| 8 | 26990-71-6 | 5-METHOXY-1,3-DIMETHYL-1H-PYRAZOLE-4-CARBALDEHYDE | C7H10N2O2 | 154.17 | 56-58°C | |
| 9 | 2699028-49-2 | 2,5-BMeS-p-A-NHS | C15H19N3O8S2 | 433.46 | | |
| 10 | 2699034-69-8 | Verenafusp alfa | | | | |
| 11 | 2699066-62-9 | Cyclooctyne-O-amido-PEG4-VC-PAB-Gly-Gly-NH-O-CO-Exatecan | | | | |
| 12 | 2699090-78-1 | 7H-Dibenzo[de,h]quinolin-7-one, 5-[4-(2-methyl-1-piperidinyl)butoxy]- | C26H28N2O2 | 400.51 | | |
| 13 | 2699091-15-9 | 1(2H)-Isoquinolinone, 2-ethyl-6-[5-fluoro-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-4-pyrimidinyl]-3,4-dihydro-, hydrochloride (1:1) | C24H27ClFN7O | 483.98 | | |
| 14 | 26991-52-6 | 5β-Pregnane-3,12-dione | C21H32O2 | 316.48 | | |
| 15 | 26991-58-2 | 5β-Androstane-3,6,17-trione | C19H26O3 | 302.41 | | |
| 16 | 26991-60-6 | 5α-Pregnane-3,7,20-trione | C21H30O3 | 330.46 | | |
| 17 | 2699147-42-5 | Butyl 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-α,α-dimethylbenzeneacetate | C32H45N3O3 | 519.72 | | |
| 18 | 26992-10-9 | Isoquinoline, 3-(6-ethenyl-1,3-benzodioxol-5-yl)-1,2,3,4-tetrahydro-7,8-dimethoxy-2-methyl- | C21H23NO4 | 353.41 | | |
| 19 | 26992-36-9 | (6bR,14bR)-6b,12,13,14b-Tetrahydro-3,3,11,11-tetramethyl-3H,7H,11H-[1]benzopyrano[6',5':4,5]furo[3,2-c]pyrano[3,2-g][1]benzopyran | C25H26O4 | 390.47 | | |
| 20 | 26992-37-0 | (6bR,12bR)-6bβ,12bβ-Dihydro-3,3-dimethyl-11-(3-methyl-2-butenyl)-3H,7H-furo[3,2-c:5,4-f']bis[1]benzopyran-10-ol | C25H26O4 | 390.47 | | |
| 21 | 26992-38-1 | (6aR,11aR)-6aα,11aα-Dihydro-2,8-bis(3-methyl-2-butenyl)-6H-benzofuro[3,2-c][1]benzopyran-3,9-diol | C25H28O4 | 392.49 | | |
| 22 | 26992-52-9 | (+)-Vaginol | C14H14O5 | 262.26 | | |
| 23 | 26993-01-1 | 2,5-Pyrrolidinedione, 1-methyl-3-phenyl-3-(phenylmethyl)- | C18H17NO2 | 279.33 | | |
| 24 | 26993-16-8 | 4'-FORMYLPHENYL-BETA-D-GLUCOPYRANOSIDE | C13H16O7 | 284.26 | 156-158 °C | |
| 25 | 26993-30-6 | Protein A | C18H38NO5P | 379.47 | 179-189°C | |
| 26 | 26993-30-6 | D-erythro-sphingosine-1-phosphate | C18H38NO5P | 379.472 | 179-189℃ | |
| 27 | 26993-32-8 | (E)-2-Hexadecen-1-ol | C16H32O | 240.42 | | |
| 28 | 26995-77-7 | 2-Heptanone, 3,7-diamino-1-chloro-, (S)- (9CI) | C7H15ClN2O | 178.66 | | |
| 29 | 26995-91-5 | UROFOLLITROPIN | C42H65N11O12S2 | 980.16 | | |
| 30 | 26995-94-8 | 3-(Methylthio)acrylic acid | C4H6O2S | 118.15 | | |
| 31 | 26995-96-0 | 2-Heptanone, 3,7-diamino-1-chloro- | C7H15ClN2O | 178.66 | | |
| 32 | 26996-03-2 | OLETH-8 | C34H68O9 | 620.9 | | |
| 33 | 26996-80-5 | (±)-Cherylline | C17H19NO3 | 285.34 | | |
| 34 | 2699603-89-7 | 4H-1,3-Oxazine-5-methanol, 2-[[3,5-difluoro-4-[[5-(2-fluoro-4-methoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenyl]amino]-5,6-dihydro-5-methyl- | C25H22F3N5O4 | 513.47 | | |
| 35 | 2699604-50-5 | 1H-Pyrrolo[2,3-b]pyridine-5-carbonitrile, 4-[2,6-difluoro-4-(5-oxa-7-azaspiro[2.5]oct-6-en-6-ylamino)phenoxy]-3-(4-fluorophenyl)- | C26H18F3N5O2 | 489.45 | | |
| 36 | 2699605-96-2 | 1,3,2-Dioxaborolane, 4,4,5-trimethyl-2-[1-(trifluoromethyl)ethenyl]- | C8H12BF3O2 | 207.99 | | |
| 37 | 2699606-99-8 | C18 dihydro Ceramide-d3 (d18:0/18:0-d3) | C36H70D3NO3 | 571 | | |
| 38 | 2699607-01-5 | 5'-Deoxy-5'-methylthioadenosine-d3 | C11H12D3N5O3S | 300.35 | | |
| 39 | 2699607-18-4 | ()-cis-Epoxiconazole-d4 | C17H9ClD4FN3O | 333.78 | | |
| 40 | 2699607-19-5 | (±)11(12)-EET-d11 | C21H34O3 | 334.5 | | |
| 41 | 2699607-22-0 | Penicillin V Potassium-d5 | C16H19KN2O5S | 390.5 | | |
| 42 | 2699607-26-4 | Propiconazole-d3 nitrate | C15H14Cl2D3N3O2.HNO3 | 408.25 | | |
| 43 | 2699607-45-7 | N-Arachidonoyl-L-Serine-d8 | C23H29D8NO4 | 399.593474224 | | |
| 44 | 2699607-47-9 | Dapoxetine-D7 HCl | C21H24ClNO | 341.88 | | |
| 45 | 2699607-48-0 | Cobicistat-d8 | C40H45D8N7O5S2 | 784.08 | | |
| 46 | 2699607-49-1 | CML-d3 | C8H16N2O4 | 204.23 | | |
| 47 | 2699607-50-4 | | C18H21ClFN3O4 | 397.83 | | |
| 48 | 2699607-85-5 | Ondansetron-13C-D3 | C18H16D3N3O | 297.390445334 | | |
| 49 | 2699607-86-6 | Tigecycline-d9 | C29H39N5O8 | 585.66 | | |
| 50 | 2699607-96-8 | Glimepiride-d4(phenylethyl-α,α,β,β-d4)(cis/trans) | C24H30D4N4O5S | 494.64 | | |
| 51 | 2699608-06-3 | N-Octadecanoyl-sulfatide-d3 | | | | |
| 52 | 2699608-18-7 | | C26H23N7O2 | 465.52 | | |
| 53 | 2699608-28-9 | NA | C34H23D5N4O4 | 561.64 | | |
| 54 | 2699608-29-0 | INDEX NAME NOT YET ASSIGNED | C21H23D11O3 | 345.56 | | |
| 55 | 2699626-96-3 | 2-Piperidinone, 1-benzoyl-3-ethyl-3-[2-(4,4,5,5-tetramethyl-1,3-dioxolan-2-yl)ethyl]-, (3S)- | | | | |
| 56 | 2699626-97-4 | 2-Piperidinone, 3-ethyl-3-[2-(4,4,5,5-tetramethyl-1,3-dioxolan-2-yl)ethyl]-, (3S)- | C16H29NO3 | 283.41 | | |
| 57 | 2699627-67-1 | DRAMP18563 | | | | |
| 58 | 2699634-21-2 | N-[3-(1-Cyano-1-methylethyl)-5-(4-methyl-1H-imidazol-1-yl)phenyl]-2-fluoro-4-methyl-5-[2-[8-[(1-methyl-1H-pyrazol-4-yl)amino]imidazo[1,2-a]pyridin-3-yl]ethynyl]benzamide | C35H30FN9O | 611.67 | | |
| 59 | 2699637-60-8 | Donepezil Impurity 61 | | | | |
| 60 | 2699640-41-8 | 6-Chloro-1-[2,3-O-(1-methylethylidene)-?-D-ribofuranosyl]-N-[(1R)-1-phenylethyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine | C21H24ClN5O4 | 445.9 | | |
| 61 | 2699680-69-6 | Bisandrographolide G | | | | |
| 62 | 2699690-66-7 | (2S,5R)-2-carbamimidoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate | C7H12N4O5S | 264.26 | | |
| 63 | 2699690-67-8 | sodium (2S,5R)-2-carbamimidoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate | C7H13N4NaO5S | 288.25 | | |
| 64 | 2699690-68-9 | (2S,5R)-2-(N-methylcarbamimidoyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate | C8H14N4O5S | 278.28 | | |
| 65 | 2699690-70-3 | (2S,5R)-2-(N-ethylcarbamimidoyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogensulfate | C9H16N4O5S | 292.31 | | |
| 66 | 2699690-71-4 | sodium (2S,5R)-2-(N-ethylcarbamimidoyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate | C9H17N4NaO5S | 316.31 | | |
| 67 | 2699690-72-5 | (2S,5R)-2-(N-(2-acetamidoethyl)carbamimidoyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogensulfate | C11H19N5O6S | 349.36 | | |
| 68 | 2699690-73-6 | sodium (1R,2S,5R)-2-(N-(2-acetamidoethyl)carbamimidoyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate | C11H20N5NaO6S | 373.36 | | |
| 69 | 2699690-77-0 | ethyl 4-((2S,5R)-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboximidamido)piperidine-1-carboxylate | C15H25N5O7S | 419.45 | | |
| 70 | 2699690-82-7 | (2S,5R)-2-(N-((R)-1-(methylsulfonyl)piperidine-3-carbonyl)carbamimidoyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate | C14H23N5O8S2 | 453.49 | | |
| 71 | 2699690-83-8 | sodium (2S,5R)-2-(N-((R)-1-(methylsulfonyl)piperidine-3-carbonyl)carbamimidoyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate | C14H24N5NaO8S2 | 477.48 | | |
| 72 | 2699690-84-9 | (2S,5R)-2-(N-((R)-1-(methylsulfonyl)pyrrolidine-3-carbonyl)carbamimidoyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate | C13H21N5O8S2 | 439.46 | | |
| 73 | 2699690-85-0 | sodium (2S,5R)-2-(N-((R)-1-(methylsulfonyl)pyrrolidine-3-carbonyl)carbamimidoyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate | C13H22N5NaO8S2 | 463.46 | | |
| 74 | 26997-02-4 | Phenol, heptyl- | C13H20O | 192.2973 | | |
| 75 | 26997-25-1 | Acetic acid ethenyl ester, polymer with sodium ethenesulfonate | C6H11NaO5S | 218.2 | | |
| 76 | 2699701-99-8 | 3-Pyrrolidinecarboxamide, N-[1-(4-fluorophenyl)-3-azetidinyl]-4-phenyl-, (3S,4R)-, 2,2,2-trifluoroacetate (1:1) | C22H23F4N3O3 | 453.44 | | |
| 77 | 2699704-08-8 | 1H-Pyrrolo[2,3-b]pyridin-3-ol, 6-bromo-2,3-dihydro-2,2-dimethyl- | C9H11BrN2O | 243.1 | | |
| 78 | 2699704-09-9 | 3H-Pyrrolo[2,3-b]pyridin-3-one, 6-bromo-1,2-dihydro-2,2-dimethyl- | C9H9BrN2O | 241.08 | | |
| 79 | 2699704-20-4 | TNF-α-IN-6 | C26H25N9O2 | 495.54 | | |
| 80 | 2699724-40-6 | (E/Z)-GSK5182 | | | | |
| 81 | 2699738-08-2 | 2-(2,4-Difluoro-6-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C13H17BF2O2 | 254.08 | | |
| 82 | 2699739-44-9 | 4-(5,5-difluorotetrahydro-2H-pyran-2-yl)-5-methylpyrimidine-2-carboxylic acid | C11H12F2N2O3 | 258.22 | | |
| 83 | 2699739-46-1 | methyl 4-(5,5-difluorotetrahydro-2H-pyran-2-yl)-5-methylpyrimidine-2-carboxylate | C12H14F2N2O3 | 272.25 | | |
| 84 | 2699742-29-3 | 3-Phenyl-2′-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[9H-fluorene-9,9′-[9H]thioxanthene] | C37H31BO2S | 550.52 | | |
| 85 | 2699768-78-8 | 5-Pyrimidinecarboxamide, hexahydro-4,6-dioxo-1,3-diphenyl-2-thioxo-N-[3-(trifluoromethoxy)phenyl]- | C24H16F3N3O4S | 499.46 | | |
| 86 | 2699784-18-2 | 4-Thiazolidinone, 5-[[3-(2-benzoxazolylamino)phenyl]methylene]-2-thioxo-, (5Z)- | C17H11N3O2S2 | 353.41 | | |
| 87 | 2699792-35-1 | 4-Fluoro-2-(3-methoxybenzyl)benzaldehyde | | | | |
| 88 | 2699792-36-2 | 3-Fluoro-2-(3-methoxybenzyl)benzaldehyde | | | | |
| 89 | 2699792-37-3 | 4-Chloro-2-(3-methoxybenzyl)benzaldehyde | | | | |
| 90 | 2699792-49-7 | 5-Chloro-2-(3-methoxybenzyl)benzaldehyde | | | | |
| 91 | 2699792-51-1 | Methyl 2-(2,4,5-trimethoxybenzyl)benzoate | | | | |
| 92 | 26998-20-9 | Cobalt abietate | | | | |
| 93 | 26998-42-5 | Molybdate(2-),bis[L-cysteinato(2-)-kN,kO,kS]di-m-oxodioxodi-, (Mo-Mo)-, disodium (9CI) | C6H10Mo2N2NaO8S2- | 517.16 | | |
| 94 | 26998-80-1 | trimethylphenol | C9H12O | 136.19098 | | |
| 95 | 26998-97-0 | calcium thiobis[dodecylphenolate] | C36H56CaO2S | 592.97164 | | |
| 96 | 2699827-95-5 | Saxagliptin-13C-d2 (hydrochloride) | C17(13C)H24D2ClN3O2 | 354.88 | | |
| 97 | 2699828-16-3 | Indacaterol-d3Q: What is Indacaterol-d3 Q: What is the CAS Number of Indacaterol-d3 | C24H28N2O3 | 392.5 | | |
| 98 | 2699874-41-2 | 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-[(2-dibenzothienylmethyl)amino]-3-(1-ethylpropoxy)-, (3R,4R,5S)- | C27H32N2O4S | 480.62 | | |
| 99 | 2699877-43-3 | EGFR-IN-60 | C28H28Cl2N6O | 535.47 | | |
| 100 | 2699881-07-5 | m-PEG9-phosphonic acid ethyl ester | C23H49O12P | 548.61 | | |
| 101 | 2699881-47-3 | Mezigdomide Impurity 15 | | | | |
| 102 | 2699881-52-0 | Mezigdomide Impurity 91 | | | | |
| 103 | 26999-06-4 | butyric acid, monoester with propane-1,2,3-triol | C7H14O4 | | | |
| 104 | 26999-29-1 | O,O-diisooctyl hydrogen dithiophosphate | C16H36O2PS2 | 355.559601 | | |
| 105 | 2699909-69-6 | 2(1H)-Quinoxalinone, 5,8-dibromo-6,7-difluoro- | C8H2Br2F2N2O | 339.92 | | |
| 106 | 2699922-08-0 | 2-Azabicyclo[4.1.0]heptane-2,3-dicarboxylic acid, 2-(1,1-dimethylethyl) ester, (3R)- | C12H19NO4 | 241.28 | | |
| 107 | 2699937-04-5 | 2H-Tetrazole-2-acetamide, N-[cis-4-[[4-[(aminoiminomethyl)amino]-6-[[3-[(aminoiminomethyl)amino]-1-cyclopropyl-3-oxopropyl]amino]-1,3,5-triazin-2-yl]amino]cyclohexyl]-5-(4-fluorophenyl)-, hydrochloride (1:1) | C26H35FN16O2.ClH | 659.12 | | |
| 108 | 2699937-76-1 | (R)-4-(5-chloro-7-((3,3-dimethylbutan-2-yl)amino)-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)-3,5-difluorobenzonitrile | C18H17ClF2N6 | 390.82 | | |
| 109 | 2699939-95-0 | Didrovaltrate Impurity 55 | | | | |
| 110 | 2699946-62-6 | 3,5-Dicyclopropylbenzaldehyde | C13H14O | 186.25 | | |
| 111 | 2699962-25-7 | (1S)-1-[3-(2-cyclopropyl-4-pyridyl)-1,2,4-oxadiazol-5-yl]ethanamine hydrochloride | C12H15ClN4O | 266.73 | | |
| 112 | 2699967-49-0 | Benzene, 1,4-dibromo-2,5-diphenoxy- | C18H12Br2O2 | 420.09 | | |
| 113 | 2699978-35-1 | Cyclopamine Impurity 6 | | | | |
| 114 | 2699990-94-6 | Cyclopamine Impurity 59 | | | | |